These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 36460208)
1. Circulating progenitor cells and outcomes in patients with coronary artery disease. Dhindsa DS; Desai SR; Jin Q; Sandesara PB; Mehta A; Liu C; Tahhan AS; Nayak A; Ejaz K; Hooda A; Moazzami K; Islam SJ; Rogers SC; Almuwaqqat Z; Mokhtari A; Hesaroieh I; Ko YA; Sperling LS; Waller EK; Quyyumi AA Int J Cardiol; 2023 Feb; 373():7-16. PubMed ID: 36460208 [TBL] [Abstract][Full Text] [Related]
2. Progenitor Cells and Clinical Outcomes in Patients With Acute Coronary Syndromes. Samman Tahhan A; Hammadah M; Raad M; Almuwaqqat Z; Alkhoder A; Sandesara PB; Mohamed-Kelli H; Hayek SS; Kim JH; O'Neal WT; Topel ML; Grant AJ; Sabbak N; Heinl RE; Gafeer MM; Obideen M; Kaseer B; Abdelhadi N; Ko YA; Liu C; Hesaroieh I; Mahar EA; Vaccarino V; Waller EK; Quyyumi AA Circ Res; 2018 May; 122(11):1565-1575. PubMed ID: 29514830 [TBL] [Abstract][Full Text] [Related]
3. Circulating Progenitor Cells and Racial Differences. Samman Tahhan A; Hammadah M; Kelli HM; Kim JH; Sandesara PB; Alkhoder A; Kaseer B; Gafeer MM; Topel M; Hayek SS; O'Neal WT; Obideen M; Ko YA; Liu C; Hesaroieh I; Mahar E; Vaccarino V; Waller EK; Quyyumi AA Circ Res; 2018 Aug; 123(4):467-476. PubMed ID: 29930146 [TBL] [Abstract][Full Text] [Related]
4. Circulating progenitor cells and coronary microvascular dysfunction: Results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation - Coronary Vascular Dysfunction Study (WISE-CVD). Mekonnen G; Hayek SS; Mehta PK; Li Q; Mahar E; Mou L; Kenkre TS; Petersen JW; Azarbal B; Samuels B; Anderson RD; Sedlak T; Zaya M; Agarwal M; Haftbaradaran A; Minissian M; Handberg E; Pepine CJ; Cogle CR; Bairey Merz CN; Waller EK; Quyyumi AA Atherosclerosis; 2016 Oct; 253():111-117. PubMed ID: 27596135 [TBL] [Abstract][Full Text] [Related]
5. Circulating Progenitor Cells in Patients With Coronary Artery Disease and Renal Insufficiency. Mehta A; Tahhan AS; Liu C; Dhindsa DS; Nayak A; Hooda A; Moazzami K; Islam SJ; Rogers SC; Almuwaqqat Z; Mokhtari A; Hesaroieh I; Ko YA; Waller EK; Quyyumi AA JACC Basic Transl Sci; 2020 Aug; 5(8):770-782. PubMed ID: 32875168 [TBL] [Abstract][Full Text] [Related]
6. Circulating progenitor cells are associated with plaque progression and long-term outcomes in heart transplant patients. Ozcan I; Toya T; Corban MT; Ahmad A; Loeffler D; Morse D; Lerman LO; Kushwaha SS; Lerman A Cardiovasc Res; 2022 Jun; 118(7):1703-1712. PubMed ID: 34132771 [TBL] [Abstract][Full Text] [Related]
7. Association Between Change in Circulating Progenitor Cells During Exercise Stress and Risk of Adverse Cardiovascular Events in Patients With Coronary Artery Disease. Moazzami K; Lima BB; Hammadah M; Ramadan R; Al Mheid I; Kim JH; Alkhoder A; Obideen M; Levantsevych O; Shah A; Liu C; Bremner JD; Kutner M; Sun YV; Waller EK; Hesaroieh IG; Raggi P; Vaccarino V; Quyyumi AA JAMA Cardiol; 2020 Feb; 5(2):147-155. PubMed ID: 31799987 [TBL] [Abstract][Full Text] [Related]
8. Circulating CD34+ progenitor cells and risk of mortality in a population with coronary artery disease. Patel RS; Li Q; Ghasemzadeh N; Eapen DJ; Moss LD; Janjua AU; Manocha P; Kassem HA; Veledar E; Samady H; Taylor WR; Zafari AM; Sperling L; Vaccarino V; Waller EK; Quyyumi AA Circ Res; 2015 Jan; 116(2):289-297. PubMed ID: 25323857 [TBL] [Abstract][Full Text] [Related]
9. Progenitor Cells and Clinical Outcomes in Patients With Heart Failure. Samman Tahhan A; Hammadah M; Sandesara PB; Hayek SS; Kalogeropoulos AP; Alkhoder A; Mohamed Kelli H; Topel M; Ghasemzadeh N; Chivukula K; Ko YA; Aida H; Hesaroieh I; Mahar E; Kim JH; Wilson P; Shaw L; Vaccarino V; Waller EK; Quyyumi AA Circ Heart Fail; 2017 Aug; 10(8):. PubMed ID: 28790053 [TBL] [Abstract][Full Text] [Related]
10. Relation between the frequency of CD34⁺ bone marrow derived circulating progenitor cells and the number of diseased coronary arteries in patients with myocardial ischemia and diabetes. Bozdag-Turan I; Turan RG; Turan CH; Ludovicy S; Akin I; Kische S; Arsoy NS; Schneider H; Ortak J; Rehders T; Hermann T; Paranskaya L; Kohlschein P; Bastian M; Ulus AT; Sahin K; Ince H; Nienaber CA Cardiovasc Diabetol; 2011 Nov; 10():107. PubMed ID: 22118372 [TBL] [Abstract][Full Text] [Related]
12. Factors influencing spontaneous mobilization of CD34+ and CD133+ progenitor cells after myocardial infarction. Turan RG; Brehm M; Koestering M; Tobias Z; Bartsch T; Steiner S; Picard F; Ebner P; Schannwell CM; Strauer BE Eur J Clin Invest; 2007 Nov; 37(11):842-51. PubMed ID: 17973780 [TBL] [Abstract][Full Text] [Related]
13. Associations Between Inflammation, Cardiovascular Regenerative Capacity, and Cardiovascular Events: A Cohort Study. Almuwaqqat Z; Hwan Kim J; Garcia M; Ko YA; Moazzami K; Lima B; Sullivan S; Alkhalaf J; Mehta A; Shah AJ; Hussain MS; Pearce BD; Bremner JD; Waller EK; Vaccarino V; Quyyumi AA Arterioscler Thromb Vasc Biol; 2021 Nov; 41(11):2814-2822. PubMed ID: 34551591 [TBL] [Abstract][Full Text] [Related]
14. Sex Differences in Circulating Progenitor Cells. Topel ML; Hayek SS; Ko YA; Sandesara PB; Samman Tahhan A; Hesaroieh I; Mahar E; Martin GS; Waller EK; Quyyumi AA J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28974500 [TBL] [Abstract][Full Text] [Related]
15. Circulating Progenitor Cells and Cognitive Impairment in Men and Women with Coronary Artery Disease. Moazzami K; Wittbrodt MT; Lima BB; Kim JH; Hammadah M; Ko YA; Obideen M; Abdelhadi N; Kaseer B; Gafeer MM; Nye JA; Shah AJ; Ward L; Raggi P; Waller EK; Bremner JD; Quyyumi AA; Vaccarino V J Alzheimers Dis; 2020; 74(2):659-668. PubMed ID: 32083582 [TBL] [Abstract][Full Text] [Related]
16. Endothelial progenitor cells, atheroma burden and clinical outcome in patients with coronary artery disease. Padfield GJ; Tura-Ceide O; Freyer E; Barclay GR; Turner M; Newby DE; Mills NL Heart; 2013 Jun; 99(11):791-8. PubMed ID: 23390050 [TBL] [Abstract][Full Text] [Related]
17. Osteocalcin positive CD133+/CD34-/KDR+ progenitor cells as an independent marker for unstable atherosclerosis. Flammer AJ; Gössl M; Widmer RJ; Reriani M; Lennon R; Loeffler D; Shonyo S; Simari RD; Lerman LO; Khosla S; Lerman A Eur Heart J; 2012 Dec; 33(23):2963-9. PubMed ID: 22855739 [TBL] [Abstract][Full Text] [Related]
18. Enhanced mobilization of CD34(+) progenitor cells expressing cell adhesion molecules in patients with STEMI. Brehm M; Ebner P; Picard F; Urbien R; Turan G; Strauer BE Clin Res Cardiol; 2009 Aug; 98(8):477-86. PubMed ID: 19479183 [TBL] [Abstract][Full Text] [Related]
19. Circulating Stem/Progenitor Cells as Prognostic Biomarkers in Macro- and Microvascular Disease: A Narrative Review of Prospective Observational Studies. Rigato M; Fadini GP Curr Med Chem; 2018; 25(35):4507-4517. PubMed ID: 28933297 [TBL] [Abstract][Full Text] [Related]
20. Improved mobilization of the CD34(+) and CD133(+) bone marrow-derived circulating progenitor cells by freshly isolated intracoronary bone marrow cell transplantation in patients with ischemic heart disease. Turan RG; Bozdag-Turan I; Ortak J; Akin I; Kische S; Schneider H; Turan CH; Rehders TC; Rauchhaus M; Kleinfeldt T; Adolph E; Brehm M; Yokus S; Steiner S; Sahin K; Nienaber CA; Ince H Stem Cells Dev; 2011 Sep; 20(9):1491-501. PubMed ID: 21190450 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]